Concurrent intratumoral injection of CXCL13 and CCL21 increased the influx of CC-chemokine receptor 5 (CCR5)-expressing B and CCR5/CCR7-expressingT cells in the TME, inducing TLS formation and resulting in reduced tumor progression in PDAC mice (60). Here, CXCL13 is linked to neoplasm.